financetom
Business
financetom
/
Business
/
Why BigBear.ai (BBAI) Stock Soared At The Open Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why BigBear.ai (BBAI) Stock Soared At The Open Today
Nov 12, 2025 8:45 AM

BigBear.ai Holdings Inc ( BBAI ) shares are trading higher Wednesday, extending a multi-day rally sparked by strong third-quarter financial results and a strategic expansion. Here’s what investors need to know.

BBAI is charging ahead with explosive momentum. Get the complete analysis here.

What To Know: The momentum follows the company's Monday report, where third-quarter revenue came in at $33.14 million, beating analyst estimates of $31.82 million. The company also posted a narrower-than-expected loss of three cents per share, outperforming the projected seven-cent loss.

While revenue was down 20% year-over-year due to lower Army program volumes, BigBear.ai ( BBAI ) reaffirmed its full-year 2025 revenue guidance of $125 million to $140 million.

Investor optimism is further fueled by the announced acquisition of Ask Sage, a generative AI platform specializing in secure government environments.

Following the news, H.C. Wainwright analyst Scott Buck reiterated a Buy rating with an $8 price target, citing the deal as a “swing factor” for 2026. Buck projects the acquisition will help drive 2026 revenue to $200 million and improve margins via SaaS-like recurring revenue.

Benzinga Edge Rankings: Underscoring this recent market enthusiasm, Benzinga Edge data currently assigns the stock a Momentum score of 96.45.

BBAI Price Action: BigBear.ai ( BBAI ) shares were up 16.09% at $7.03 at the time of publication on Wednesday, according to Benzinga Pro data.

Read Also: Goldman Sees S&P 500 At 9,000 By 2030—But The Real Boom Lies Elsewhere

How To Buy BBAI Stock

By now you're likely curious about how to participate in the market for BigBear.ai ( BBAI ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sernova Secures $1 Million in Convertible Debt Financing
Sernova Secures $1 Million in Convertible Debt Financing
Mar 5, 2025
09:51 AM EST, 03/05/2025 (MT Newswires) -- Sernova Biotherapeutics (SVA.TO), a regenerative medicine company trading near 52-week lows, on Wednesday announced a $1 million unsecured convertible debenture financing with Dr. Steven Sangha, a Sernova ( SEOVF ) shareholder and board member. The debenture is repayable on March 4, 2027, unless earlier converted or redeemed, and carries a 15% interest rate....
Update: Thor Industries Swings to Fiscal Q2 Loss, Revenue Decreases; Adjusts 2025 Guidance
Update: Thor Industries Swings to Fiscal Q2 Loss, Revenue Decreases; Adjusts 2025 Guidance
Mar 5, 2025
10:05 AM EST, 03/05/2025 (MT Newswires) -- (Updates with the latest stock movement in the first paragraph.) Thor Industries ( THO ) shares were down nearly 12% in recent Wednesday trading after the company swung to a Q2 loss and posted lower revenue. The company reported a fiscal Q2 loss of $0.01 per diluted share, swinging from earnings of $0.13...
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
Mar 5, 2025
DUESSELDORF, Germany (Reuters) -A German court on Wednesday ruled that Pfizer ( PFE ) and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna ( MRNA ). In a statement, the court in the city of Duesseldorf said that Pfizer ( PFE ) and BioNTech would have to provide information on earnings derived from the use of the...
Campbell's Tempers Fiscal 2025 Outlook After Second-Quarter Sales Miss
Campbell's Tempers Fiscal 2025 Outlook After Second-Quarter Sales Miss
Mar 5, 2025
10:01 AM EST, 03/05/2025 (MT Newswires) -- Campbell's (CPB), formerly known as Campbell Soup, on Wednesday reported fiscal second-quarter revenue that fell short of analysts' expectations, while the consumer packaged food firm cut its 2025 outlook. Net sales rose to $2.69 billion during the three months ended Jan. 26 from $2.46 billion a year earlier, but trailed the FactSet-polled consensus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved